Cargando…

Gradual deterioration of fatty liver disease to liver cancer via inhibition of AMPK signaling pathways involved in energy-dependent disorders, cellular aging, and chronic inflammation

INTRODUCTION: Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer kind. According to recent research, a fatty liver increases the risk of hepatocellular cancer. Nevertheless, the AMPK signaling pathway is crucial. In addition, 5’-AMP-activated protein kinase (AMPK) is strongly...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Sha-Sha, Gu, Hong-Wei, Zhang, Ting, Li, Yu-Sang, Tang, He-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018212/
https://www.ncbi.nlm.nih.gov/pubmed/36937390
http://dx.doi.org/10.3389/fonc.2023.1099624
_version_ 1784907766179037184
author Meng, Sha-Sha
Gu, Hong-Wei
Zhang, Ting
Li, Yu-Sang
Tang, He-Bin
author_facet Meng, Sha-Sha
Gu, Hong-Wei
Zhang, Ting
Li, Yu-Sang
Tang, He-Bin
author_sort Meng, Sha-Sha
collection PubMed
description INTRODUCTION: Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer kind. According to recent research, a fatty liver increases the risk of hepatocellular cancer. Nevertheless, the AMPK signaling pathway is crucial. In addition, 5’-AMP-activated protein kinase (AMPK) is strongly linked to alterations in the tumor microenvironment, such as inflammation, hypoxia, and aging. The objective of this study is to evaluate the impact of the AMPK signaling pathway on the progression of fatty liver to HCC. METHODS: In this study, we established a mouse liver cancer model using high-fat diets and nano-nitrosamines (nano-DEN). In addition, we employed a transcriptomic technique to identify all mRNAs detected in liver samples at the 25th weekexpression of proteins linked with the LKB1-AMPK-mTOR signaling pathway, inflammation, aging, and hypoxia was studied in microarrays of liver cancer tissues from mice and humans. These proteins included p-AMPK, LKB1, mTOR, COX-2, β-catenin, HMGB1, p16, and HIF-1α. RESULTS: Data were collected at different times in the liver as well as in cancerous and paracancerous regions and analyzed by a multispectral imaging system. The results showed that most of the genes in the AMPK signaling pathway were downregulated. Prakk1 expression was upregulated compared to control group but downregulated in the cancerous regions compared to the paracancerous regions. Stk11 expression was downregulated in the cancerous regions. Mtor expression was upregulated in the cancerous regions. During liver cancer formation, deletion of LKB1 in the LKB1-AMPK-mTOR signaling pathway reduces phosphorylation of AMPK. It contributed to the upregulation of mTOR, which further led to the upregulation of HIF1α. In addition, the expression of β-catenin, COX-2, and HMGB1 were upregulated, as well as the expression of p16 was downregulated. DISCUSSION: These findings suggest that changes in the AMPK signaling pathway exacerbate the deterioration of disrupted energy metabolism, chronic inflammation, hypoxia, and cellular aging in the tumor microenvironment, promoting the development of fatty liver into liver cancer.
format Online
Article
Text
id pubmed-10018212
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-100182122023-03-17 Gradual deterioration of fatty liver disease to liver cancer via inhibition of AMPK signaling pathways involved in energy-dependent disorders, cellular aging, and chronic inflammation Meng, Sha-Sha Gu, Hong-Wei Zhang, Ting Li, Yu-Sang Tang, He-Bin Front Oncol Oncology INTRODUCTION: Hepatocellular carcinoma (HCC) is the most prevalent primary liver cancer kind. According to recent research, a fatty liver increases the risk of hepatocellular cancer. Nevertheless, the AMPK signaling pathway is crucial. In addition, 5’-AMP-activated protein kinase (AMPK) is strongly linked to alterations in the tumor microenvironment, such as inflammation, hypoxia, and aging. The objective of this study is to evaluate the impact of the AMPK signaling pathway on the progression of fatty liver to HCC. METHODS: In this study, we established a mouse liver cancer model using high-fat diets and nano-nitrosamines (nano-DEN). In addition, we employed a transcriptomic technique to identify all mRNAs detected in liver samples at the 25th weekexpression of proteins linked with the LKB1-AMPK-mTOR signaling pathway, inflammation, aging, and hypoxia was studied in microarrays of liver cancer tissues from mice and humans. These proteins included p-AMPK, LKB1, mTOR, COX-2, β-catenin, HMGB1, p16, and HIF-1α. RESULTS: Data were collected at different times in the liver as well as in cancerous and paracancerous regions and analyzed by a multispectral imaging system. The results showed that most of the genes in the AMPK signaling pathway were downregulated. Prakk1 expression was upregulated compared to control group but downregulated in the cancerous regions compared to the paracancerous regions. Stk11 expression was downregulated in the cancerous regions. Mtor expression was upregulated in the cancerous regions. During liver cancer formation, deletion of LKB1 in the LKB1-AMPK-mTOR signaling pathway reduces phosphorylation of AMPK. It contributed to the upregulation of mTOR, which further led to the upregulation of HIF1α. In addition, the expression of β-catenin, COX-2, and HMGB1 were upregulated, as well as the expression of p16 was downregulated. DISCUSSION: These findings suggest that changes in the AMPK signaling pathway exacerbate the deterioration of disrupted energy metabolism, chronic inflammation, hypoxia, and cellular aging in the tumor microenvironment, promoting the development of fatty liver into liver cancer. Frontiers Media S.A. 2023-03-02 /pmc/articles/PMC10018212/ /pubmed/36937390 http://dx.doi.org/10.3389/fonc.2023.1099624 Text en Copyright © 2023 Meng, Gu, Zhang, Li and Tang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Meng, Sha-Sha
Gu, Hong-Wei
Zhang, Ting
Li, Yu-Sang
Tang, He-Bin
Gradual deterioration of fatty liver disease to liver cancer via inhibition of AMPK signaling pathways involved in energy-dependent disorders, cellular aging, and chronic inflammation
title Gradual deterioration of fatty liver disease to liver cancer via inhibition of AMPK signaling pathways involved in energy-dependent disorders, cellular aging, and chronic inflammation
title_full Gradual deterioration of fatty liver disease to liver cancer via inhibition of AMPK signaling pathways involved in energy-dependent disorders, cellular aging, and chronic inflammation
title_fullStr Gradual deterioration of fatty liver disease to liver cancer via inhibition of AMPK signaling pathways involved in energy-dependent disorders, cellular aging, and chronic inflammation
title_full_unstemmed Gradual deterioration of fatty liver disease to liver cancer via inhibition of AMPK signaling pathways involved in energy-dependent disorders, cellular aging, and chronic inflammation
title_short Gradual deterioration of fatty liver disease to liver cancer via inhibition of AMPK signaling pathways involved in energy-dependent disorders, cellular aging, and chronic inflammation
title_sort gradual deterioration of fatty liver disease to liver cancer via inhibition of ampk signaling pathways involved in energy-dependent disorders, cellular aging, and chronic inflammation
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018212/
https://www.ncbi.nlm.nih.gov/pubmed/36937390
http://dx.doi.org/10.3389/fonc.2023.1099624
work_keys_str_mv AT mengshasha gradualdeteriorationoffattyliverdiseasetolivercancerviainhibitionofampksignalingpathwaysinvolvedinenergydependentdisorderscellularagingandchronicinflammation
AT guhongwei gradualdeteriorationoffattyliverdiseasetolivercancerviainhibitionofampksignalingpathwaysinvolvedinenergydependentdisorderscellularagingandchronicinflammation
AT zhangting gradualdeteriorationoffattyliverdiseasetolivercancerviainhibitionofampksignalingpathwaysinvolvedinenergydependentdisorderscellularagingandchronicinflammation
AT liyusang gradualdeteriorationoffattyliverdiseasetolivercancerviainhibitionofampksignalingpathwaysinvolvedinenergydependentdisorderscellularagingandchronicinflammation
AT tanghebin gradualdeteriorationoffattyliverdiseasetolivercancerviainhibitionofampksignalingpathwaysinvolvedinenergydependentdisorderscellularagingandchronicinflammation